(Q36164034)

English

The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 August 2017

The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer (English)

1 reference

Europe PubMed Central

12 August 2017

neuroendocrinology

1 reference

based on heuristic

inferred from title

phaeochromocytoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

object named as

M Sue O'Dorisio

0 references

North American Neuroendocrine Tumor Society

7

object named as

North American Neuroendocrine Tumor Society (NANETS)

0 references

6

object named as

Karel Pacak

1 reference

Europe PubMed Central

12 August 2017

author name string

Herbert Chen

1

1 reference

Europe PubMed Central

12 August 2017

Rebecca S Sippel

2

1 reference

Europe PubMed Central

12 August 2017

M Sue O'Dorisio

3

1 reference

Europe PubMed Central

12 August 2017

Aaron I Vinik

4

1 reference

Europe PubMed Central

12 August 2017

Ricardo V Lloyd

5

1 reference

Europe PubMed Central

12 August 2017

North American Neuroendocrine Tumor Society (NANETS)

7

1 reference

Europe PubMed Central

12 August 2017

publication date

1 August 2010

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

39

1 reference

Europe PubMed Central

12 August 2017

6

1 reference

Europe PubMed Central

12 August 2017

775-783

1 reference

Europe PubMed Central

12 August 2017

Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Current management of medullary thyroid cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Preoperative management of the pheochromocytoma patient

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Pheochromocytoma as a catecholamine producing tumor: implications for clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Medullary thyroid cancer: therapeutic targets and molecular markers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Phaeochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Functional imaging of endocrine tumors: role of positron emission tomography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

The role of human achaete-scute homolog-1 in medullary thyroid cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Pheochromocytoma: the expanding genetic differential diagnosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Germ-line mutations in nonsyndromic pheochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Biochemical diagnosis of pheochromocytoma: which test is best?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Pheochromocytomas: detection with 18F DOPA whole body PET--initial results..

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Guidelines for diagnosis and therapy of MEN type 1 and type 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

[(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

The perioperative management of children with phaeochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Hereditary endocrinopathies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Clinical experience over 48 years with pheochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 October 2017

Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

2 July 2018

123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

131I-MIBG therapy in metastatic phaeochromocytoma and paraganglioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

Recent advances in the diagnosis and treatment of pheochromocytoma in children.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

The use of 18-fluoro-dihydroxyphenylalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine-negative phaeochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

Genetic testing in pheochromocytoma or functional paraganglioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

Extent of disease and practice patterns for medullary thyroid cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

Utility of plasma free metanephrines for detecting childhood pheochromocytoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3419007

23 September 2018

Pheochromocytoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rationale for Central and Bilateral Lymph Node Dissection in Sporadic and Hereditary Medullary Thyroid Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reoperation for recurrent or persistent medullary thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical management of patients with persistent or recurrent medullary thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hereditary medullary thyroid carcinoma in patients greater than 50 years old

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas--experience and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of pheochromocytoma in a 4- to 20-year-old population

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequent genetic changes in childhood pheochromocytomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radioguided parathyroidectomy in patients with familial hyperparathyroidism

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is supine rest necessary before blood sampling for plasma metanephrines?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial lymph node dissection increases cure rates in patients with medullary thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II trial of imatinib therapy for metastatic medullary thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664475

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/MPA.0B013E3181EBB4F0

1 reference

Europe PubMed Central

12 August 2017

release_5sqdetvlmzgrdj3bbdmyi5j2we

1 reference

https://api.fatcat.wiki/v0/release/5sqdetvlmzgrdj3bbdmyi5j2we

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

12 August 2017

1 reference

Europe PubMed Central

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36164034&oldid=1977999685"